B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type), A/Victoria/2570/2019 (H1N1)Pdm09-Like Strain (A/Victoria/2570/2019, Ivr-215), Influenza Virus B/Michigan/01/2021, Influenza Virus A/Darwin/9/2021 Ivr-228 (H3N2)

3 trials 2 recruiting JAnti-infectives

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

3 Sponsors

3 Countries

Phase III

Phase IV

Phase III: 2 Phase IV: 1

Sponsors using this IMP

CHU De Liege 1 Complexo Hospitalario Universitario De Santiago 1 Janssen Vaccines & Prevention B.V. 1

All trials

3 total

Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenz… Recruiting

2023-506977-36-00 Phase IV 1 country Complexo Hospitalario Universitario De Santiago
A Single-Blind randomized trial of High-Dose versus Standard-Dose Inactivated Influenza Vaccine in Adult Patients Treated for an Hematologic… Recruiting

2023-505357-40-00 Phase III 1 country CHU De Liege
A Phase 3 Randomized Double-blind Controlled Study to Evaluate the Immunogenicity, Safety, and Reactogenicity of ExPEC9V and High-dose Quadr… Ended

2023-504168-40-00 Phase III 2 countries Janssen Vaccines & Prevention B.V.

Showing 1–3 of 3 trials

← All drugs A–Z